Company News

MyoStrain® Aids Diagnostic Classification of Cardiac Amyloidosis, Rare Disease in Which Early Treatment Could Improve Patient Outcomes
Myocardial Solutions’ software, MyoStrain, was featured in a new Vascular Health and Risk Management publication evaluating the use of cardiac imaging techniques in the diagnostic work-up for patients with suspected cardiac amyloidosis. Cardiac amyloidosis is a serious, progressive disease that....
This is some text inside of a div block.
November 23, 2021
Myocardial Solutions Welcomes Three New Members to the Board of Directors
Myocardial Solutions (“MSI”) announced the addition of three new board members: Bob Kay, Jeff Barber and Gary Brock. Jeff replaces Bill Burke as Chair of the Audit Committee. Bill was an outstanding Director but was forced to resign as a result of new time commitments after becoming Chairman...
This is some text inside of a div block.
August 26, 2021
Myocardial Solutions Launches New Dynamic Website to Expand Clinical Education of MyoStrain®
Myocardial Solutions (“MSI”) announced the launch of their new dynamic website Monday to support the growing commercial and clinical initiatives to drive MyoStrain adoption. The newly updated website features an improved...
This is some text inside of a div block.
August 16, 2021
New Study Demonstrates MyoStrain® Ability to Differentiate Between Varying Levels of Left Ventricular Hypertrophy to Help Optimize Therapy
Myocardial Solutions’ software platform, MyoStrain, was featured in a new Journal of Cardiovascular Magnetic Resonance publication evaluating a multiparametric assessment of left ventricular hypertrophy (LVH). LVH, which can be a result of an array of diseases and conditions, makes determining the..
This is some text inside of a div block.
July 22, 2021
New Study Demonstrates MyoStrain® Ability to Detect Subclinical Cardiac Dysfunction in Patients With Wilson Disease
A recent study published in the Journal of Cardiovascular Magnetic Resonance featured Myocardial Solutions’ technology MyoStrain, where MyoStrain was used to examine myocardial tissue function in Wilson Disease (WD) patients. WD, a storage disease that results in...
This is some text inside of a div block.
July 12, 2021

Get Email Alerts

Subscribe to the newsletter to receive instant email notifications and alerts when news comes MyoStrain® and Myocardial Solutions, Inc.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.